Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/127623
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Carmona, F. Javier | - |
dc.contributor.author | Berdasco, María | - |
dc.contributor.author | Esteller, Manel | - |
dc.contributor.author | Kulis, Marta | - |
dc.contributor.author | Queirós, Ana C. | - |
dc.contributor.author | Martín-Subero, José Ignacio | - |
dc.contributor.author | BLUEPRINT consortium | - |
dc.date.accessioned | 2019-01-25T13:04:33Z | - |
dc.date.available | 2019-01-25T13:04:33Z | - |
dc.date.issued | 2016-06-27 | - |
dc.identifier.issn | 1087-0156 | - |
dc.identifier.uri | http://hdl.handle.net/2445/127623 | - |
dc.description.abstract | DNA methylation patterns are altered in numerous diseases and often correlate with clinically relevant information such as disease subtypes, prognosis and drug response. With suitable assays and after validation in large cohorts, such associations can be exploited for clinical diagnostics and personalized treatment decisions. Here we describe the results of a community-wide benchmarking study comparing the performance of all widely used methods for DNA methylation analysis that are compatible with routine clinical use. We shipped 32 reference samples to 18 laboratories in seven different countries. Researchers in those laboratories collectively contributed 21 locus-specific assays for an average of 27 predefined genomic regions, as well as six global assays. We evaluated assay sensitivity on low-input samples and assessed the assays' ability to discriminate between cell types. Good agreement was observed across all tested methods, with amplicon bisulfite sequencing and bisulfite pyrosequencing showing the best all-round performance. Our technology comparison can inform the selection, optimization and use of DNA methylation assays in large-scale validation studies, biomarker development and clinical diagnostics. | - |
dc.format.extent | 12 p. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | Nature Publishing Group | - |
dc.relation.isformatof | Versió postprint del document publicat a: https://doi.org/10.1038/nbt.3605 | - |
dc.relation.ispartof | Nature Biotechnology, 2016, vol. 34, num. 7, p. 726-737 | - |
dc.relation.uri | https://doi.org/10.1038/nbt.3605 | - |
dc.rights | (c) Nature Publishing Group, 2016 | - |
dc.source | Articles publicats en revistes (Fonaments Clínics) | - |
dc.subject.classification | ADN | - |
dc.subject.classification | Marcadors bioquímics | - |
dc.subject.classification | Diagnòstic | - |
dc.subject.other | DNA | - |
dc.subject.other | Biochemical markers | - |
dc.subject.other | Diagnosis | - |
dc.title | Quantitative comparison of DNA methylation assays for biomarker development and clinical applications | - |
dc.type | info:eu-repo/semantics/article | - |
dc.type | info:eu-repo/semantics/acceptedVersion | - |
dc.identifier.idgrec | 665066 | - |
dc.date.updated | 2019-01-25T13:04:34Z | - |
dc.relation.projectID | info:eu-repo/grantAgreement/EC/FP7/282510/EU//BLUEPRINT | - |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
dc.identifier.pmid | 27347756 | - |
Appears in Collections: | Articles publicats en revistes (Fonaments Clínics) Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer) Articles publicats en revistes (Ciències Fisiològiques) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
665066.pdf | 4.99 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.